Mohammad Salajegheh, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myositis, Inclusion Body | 11 | 2014 | 147 | 2.180 |
Why?
|
| Muscular Diseases | 5 | 2018 | 555 | 1.440 |
Why?
|
| Median Neuropathy | 1 | 2021 | 8 | 0.790 |
Why?
|
| Lipomatosis | 1 | 2021 | 112 | 0.720 |
Why?
|
| Hamartoma | 1 | 2021 | 238 | 0.660 |
Why?
|
| Motor Neuron Disease | 1 | 2018 | 99 | 0.620 |
Why?
|
| Channelopathies | 1 | 2015 | 32 | 0.530 |
Why?
|
| Muscle, Skeletal | 12 | 2014 | 4925 | 0.530 |
Why?
|
| Dermatomyositis | 5 | 2013 | 224 | 0.500 |
Why?
|
| Spinal Nerve Roots | 1 | 2015 | 121 | 0.490 |
Why?
|
| Porphyrias | 1 | 2014 | 57 | 0.490 |
Why?
|
| Muscle Fibers, Skeletal | 4 | 2013 | 555 | 0.430 |
Why?
|
| Sarcoplasmic Reticulum | 2 | 2009 | 158 | 0.420 |
Why?
|
| Primary Health Care | 2 | 2018 | 4557 | 0.400 |
Why?
|
| Muscle Proteins | 3 | 2011 | 1158 | 0.380 |
Why?
|
| Electrodiagnosis | 3 | 2021 | 151 | 0.360 |
Why?
|
| Myositis | 2 | 2010 | 251 | 0.360 |
Why?
|
| Autoantigens | 3 | 2013 | 892 | 0.360 |
Why?
|
| Ubiquitins | 3 | 2013 | 384 | 0.360 |
Why?
|
| Muscle Weakness | 3 | 2021 | 413 | 0.340 |
Why?
|
| Muscle Cells | 1 | 2009 | 197 | 0.330 |
Why?
|
| Postpartum Period | 1 | 2015 | 1086 | 0.320 |
Why?
|
| Myotonia | 3 | 2013 | 18 | 0.310 |
Why?
|
| Lower Extremity | 1 | 2015 | 1158 | 0.290 |
Why?
|
| Spinal Cord Injuries | 1 | 2015 | 931 | 0.290 |
Why?
|
| Microdissection | 4 | 2010 | 152 | 0.280 |
Why?
|
| Up-Regulation | 4 | 2013 | 4222 | 0.270 |
Why?
|
| Thrombospondin 1 | 1 | 2007 | 250 | 0.270 |
Why?
|
| Poliomyelitis | 1 | 2006 | 103 | 0.260 |
Why?
|
| Interferon Type I | 5 | 2013 | 542 | 0.260 |
Why?
|
| Carpal Tunnel Syndrome | 2 | 2019 | 300 | 0.240 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2022 | 1414 | 0.230 |
Why?
|
| Autoantibodies | 2 | 2013 | 2036 | 0.230 |
Why?
|
| Cytokines | 4 | 2013 | 7323 | 0.210 |
Why?
|
| Cell Nucleus | 1 | 2009 | 2969 | 0.180 |
Why?
|
| Immunohistochemistry | 6 | 2010 | 11366 | 0.180 |
Why?
|
| tau Proteins | 1 | 2009 | 1868 | 0.180 |
Why?
|
| Lymphocytes | 1 | 2007 | 2617 | 0.170 |
Why?
|
| Diagnosis, Differential | 3 | 2021 | 12961 | 0.160 |
Why?
|
| Median Nerve | 1 | 2019 | 129 | 0.160 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2007 | 2540 | 0.160 |
Why?
|
| B-Lymphocytes | 2 | 2010 | 4666 | 0.160 |
Why?
|
| Immunoblotting | 2 | 2011 | 1683 | 0.150 |
Why?
|
| Polymyositis | 3 | 2013 | 75 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2008 | 4751 | 0.140 |
Why?
|
| Mexiletine | 2 | 2013 | 31 | 0.140 |
Why?
|
| Neuromuscular Junction Diseases | 1 | 2015 | 14 | 0.140 |
Why?
|
| 4-Aminopyridine | 1 | 2015 | 81 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2865 | 0.130 |
Why?
|
| Orphan Drug Production | 1 | 2015 | 50 | 0.130 |
Why?
|
| Potassium Channel Blockers | 1 | 2015 | 171 | 0.130 |
Why?
|
| Lumbosacral Plexus | 1 | 2015 | 53 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2009 | 4479 | 0.120 |
Why?
|
| Proteomics | 4 | 2012 | 3638 | 0.120 |
Why?
|
| RNA, Messenger | 7 | 2010 | 13035 | 0.110 |
Why?
|
| Humans | 38 | 2022 | 744366 | 0.110 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 9647 | 0.110 |
Why?
|
| Immunologic Factors | 2 | 2014 | 1580 | 0.110 |
Why?
|
| Anesthesia, Obstetrical | 1 | 2015 | 235 | 0.100 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 501 | 0.100 |
Why?
|
| Chloride Channels | 1 | 2013 | 227 | 0.100 |
Why?
|
| Interferon-beta | 2 | 2010 | 324 | 0.100 |
Why?
|
| 5'-Nucleotidase | 1 | 2013 | 160 | 0.100 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2012 | 61 | 0.100 |
Why?
|
| Muscle Strength | 2 | 2013 | 592 | 0.100 |
Why?
|
| Pain Measurement | 1 | 2021 | 3420 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 4 | 2014 | 9274 | 0.100 |
Why?
|
| Severity of Illness Index | 5 | 2022 | 15535 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2010 | 3921 | 0.090 |
Why?
|
| B-Cell Activating Factor | 1 | 2010 | 119 | 0.090 |
Why?
|
| Disease Management | 2 | 2018 | 2460 | 0.090 |
Why?
|
| Sodium Channels | 2 | 2012 | 349 | 0.090 |
Why?
|
| Congo Red | 1 | 2009 | 46 | 0.090 |
Why?
|
| B-Cell Maturation Antigen | 1 | 2010 | 140 | 0.090 |
Why?
|
| Sarcomeres | 2 | 2009 | 374 | 0.090 |
Why?
|
| HIV-1 | 1 | 2007 | 6939 | 0.090 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2009 | 69 | 0.090 |
Why?
|
| Electromyography | 1 | 2014 | 1379 | 0.080 |
Why?
|
| Dendritic Cells | 2 | 2010 | 2725 | 0.080 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2009 | 113 | 0.080 |
Why?
|
| Lymphoid Tissue | 1 | 2010 | 455 | 0.080 |
Why?
|
| Choristoma | 1 | 2010 | 214 | 0.080 |
Why?
|
| Veterans | 1 | 2022 | 2519 | 0.080 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2012 | 789 | 0.080 |
Why?
|
| Germinal Center | 1 | 2010 | 377 | 0.080 |
Why?
|
| Antibodies, Neoplasm | 1 | 2009 | 286 | 0.080 |
Why?
|
| Polyneuropathies | 1 | 2009 | 137 | 0.080 |
Why?
|
| Enzymes | 1 | 2009 | 266 | 0.080 |
Why?
|
| Cross Reactions | 1 | 2009 | 841 | 0.080 |
Why?
|
| Postpoliomyelitis Syndrome | 1 | 2007 | 11 | 0.080 |
Why?
|
| Genes, gag | 1 | 2007 | 61 | 0.080 |
Why?
|
| Antibody Specificity | 1 | 2009 | 1095 | 0.070 |
Why?
|
| Neurofilament Proteins | 1 | 2009 | 318 | 0.070 |
Why?
|
| Complementarity Determining Regions | 1 | 2007 | 149 | 0.070 |
Why?
|
| Immunoglobulin Switch Region | 1 | 2007 | 46 | 0.070 |
Why?
|
| Immunoglobulins | 1 | 2010 | 881 | 0.070 |
Why?
|
| Plasma Cells | 1 | 2010 | 591 | 0.070 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 1 | 2007 | 57 | 0.070 |
Why?
|
| Aged | 14 | 2021 | 163288 | 0.070 |
Why?
|
| Genes, MHC Class I | 1 | 2007 | 258 | 0.070 |
Why?
|
| Demyelinating Diseases | 1 | 2009 | 354 | 0.070 |
Why?
|
| Amyloid beta-Peptides | 2 | 2009 | 3587 | 0.070 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2007 | 246 | 0.070 |
Why?
|
| Lasers | 1 | 2010 | 952 | 0.070 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2005 | 90 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 2505 | 0.060 |
Why?
|
| Autoimmunity | 1 | 2013 | 1350 | 0.060 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2010 | 985 | 0.060 |
Why?
|
| Antigen Presentation | 1 | 2010 | 1284 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 1783 | 0.060 |
Why?
|
| Immunoglobulin M | 1 | 2009 | 1537 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 8861 | 0.060 |
Why?
|
| Potassium | 1 | 2008 | 1336 | 0.060 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2007 | 548 | 0.060 |
Why?
|
| Male | 16 | 2021 | 350115 | 0.060 |
Why?
|
| Middle Aged | 15 | 2019 | 213390 | 0.060 |
Why?
|
| Databases, Genetic | 1 | 2010 | 1783 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2014 | 8436 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2010 | 1640 | 0.050 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2008 | 1121 | 0.050 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 972 | 0.050 |
Why?
|
| Adult | 11 | 2019 | 214052 | 0.050 |
Why?
|
| Female | 15 | 2019 | 380193 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2009 | 5181 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2887 | 0.050 |
Why?
|
| Antibodies | 1 | 2009 | 2460 | 0.050 |
Why?
|
| Benzhydryl Compounds | 1 | 2007 | 845 | 0.050 |
Why?
|
| Indoles | 1 | 2009 | 1839 | 0.050 |
Why?
|
| HIV Infections | 1 | 2007 | 16715 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6171 | 0.050 |
Why?
|
| Fatigue | 1 | 2007 | 1531 | 0.040 |
Why?
|
| Neurilemmoma | 1 | 2005 | 547 | 0.040 |
Why?
|
| Mass Spectrometry | 3 | 2013 | 2204 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 1148 | 0.040 |
Why?
|
| Young Adult | 3 | 2014 | 56429 | 0.040 |
Why?
|
| Physicians | 1 | 2015 | 4567 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2010 | 14723 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 57776 | 0.040 |
Why?
|
| Double-Blind Method | 4 | 2014 | 12025 | 0.040 |
Why?
|
| Biopsy | 4 | 2009 | 6755 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2010 | 19233 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2007 | 4162 | 0.040 |
Why?
|
| Incidence | 1 | 2015 | 20952 | 0.030 |
Why?
|
| Meningioma | 1 | 2005 | 1209 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 4153 | 0.030 |
Why?
|
| Interferon-alpha | 2 | 2010 | 895 | 0.030 |
Why?
|
| Meningeal Neoplasms | 1 | 2005 | 1241 | 0.030 |
Why?
|
| Alleles | 1 | 2007 | 6933 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 4424 | 0.030 |
Why?
|
| Immobilization | 1 | 2016 | 236 | 0.030 |
Why?
|
| Chromatography, Liquid | 2 | 2009 | 976 | 0.030 |
Why?
|
| Cross-Over Studies | 2 | 2012 | 2029 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2015 | 25628 | 0.030 |
Why?
|
| Smad2 Protein | 1 | 2014 | 156 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2014 | 180 | 0.030 |
Why?
|
| Antibodies, Blocking | 1 | 2014 | 253 | 0.030 |
Why?
|
| Activin Receptors, Type II | 1 | 2014 | 127 | 0.030 |
Why?
|
| Thigh | 1 | 2014 | 247 | 0.030 |
Why?
|
| Myelitis, Transverse | 1 | 2013 | 39 | 0.030 |
Why?
|
| Pregnancy | 1 | 2015 | 29144 | 0.030 |
Why?
|
| Mutation | 3 | 2013 | 29786 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2013 | 1903 | 0.030 |
Why?
|
| Vacuoles | 1 | 2013 | 229 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2013 | 311 | 0.030 |
Why?
|
| Neuromuscular Diseases | 1 | 2014 | 247 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 906 | 0.020 |
Why?
|
| Glioma | 1 | 2005 | 3401 | 0.020 |
Why?
|
| Disease Progression | 2 | 2022 | 13286 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2005 | 3481 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2016 | 1487 | 0.020 |
Why?
|
| Glycogen Storage Disease Type III | 1 | 2009 | 13 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2013 | 931 | 0.020 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2010 | 106 | 0.020 |
Why?
|
| Cytosol | 1 | 2013 | 901 | 0.020 |
Why?
|
| Seveso Accidental Release | 1 | 2009 | 2 | 0.020 |
Why?
|
| Inflammation Mediators | 2 | 2009 | 1888 | 0.020 |
Why?
|
| Organ Size | 1 | 2014 | 2251 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2009 | 280 | 0.020 |
Why?
|
| Autocrine Communication | 1 | 2010 | 171 | 0.020 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2010 | 212 | 0.020 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2010 | 167 | 0.020 |
Why?
|
| Calpain | 1 | 2009 | 150 | 0.020 |
Why?
|
| Paralysis, Hyperkalemic Periodic | 1 | 2008 | 5 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2010 | 708 | 0.020 |
Why?
|
| Actinin | 1 | 2009 | 160 | 0.020 |
Why?
|
| Nuclear Envelope | 1 | 2009 | 172 | 0.020 |
Why?
|
| Gene Expression | 2 | 2011 | 7798 | 0.020 |
Why?
|
| Solubility | 1 | 2009 | 1088 | 0.020 |
Why?
|
| Biological Assay | 1 | 2010 | 652 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2009 | 414 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 411 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2009 | 608 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2009 | 383 | 0.020 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2010 | 449 | 0.020 |
Why?
|
| Exercise Test | 1 | 2014 | 2073 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2009 | 793 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2009 | 1801 | 0.020 |
Why?
|
| International Cooperation | 1 | 2013 | 1420 | 0.020 |
Why?
|
| Endopeptidases | 1 | 2010 | 772 | 0.020 |
Why?
|
| Syndecan-1 | 1 | 2007 | 165 | 0.020 |
Why?
|
| Cell Count | 1 | 2010 | 1856 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 693 | 0.020 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2007 | 421 | 0.020 |
Why?
|
| Quality of Life | 3 | 2013 | 12802 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2019 | 5984 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2010 | 970 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1730 | 0.020 |
Why?
|
| Glycolysis | 1 | 2009 | 829 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2008 | 1308 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2011 | 9445 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2012 | 3914 | 0.020 |
Why?
|
| Genome | 1 | 2013 | 1807 | 0.020 |
Why?
|
| Transcription, Genetic | 2 | 2010 | 7721 | 0.020 |
Why?
|
| Follow-Up Studies | 3 | 2011 | 39052 | 0.010 |
Why?
|
| Pedigree | 1 | 2012 | 4642 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3873 | 0.010 |
Why?
|
| Placebo Effect | 1 | 2007 | 502 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2010 | 1837 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2008 | 2184 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2009 | 2715 | 0.010 |
Why?
|
| Kinetics | 1 | 2010 | 6476 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2007 | 1402 | 0.010 |
Why?
|
| Artifacts | 1 | 2010 | 1904 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2009 | 3001 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 4805 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2007 | 2618 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2014 | 63107 | 0.010 |
Why?
|
| Gene Expression Regulation | 2 | 2009 | 12073 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 6621 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2916 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 2917 | 0.010 |
Why?
|
| Proteome | 1 | 2009 | 1798 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2009 | 2926 | 0.010 |
Why?
|
| Cell Line | 1 | 2013 | 16000 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2019 | 77460 | 0.010 |
Why?
|
| Pain | 1 | 2012 | 4988 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 4410 | 0.010 |
Why?
|
| Exercise | 1 | 2013 | 5615 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2010 | 5023 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 4386 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2013 | 11486 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 9735 | 0.010 |
Why?
|
| Brain | 1 | 2022 | 26388 | 0.010 |
Why?
|
| Proteins | 1 | 2010 | 6100 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 13814 | 0.010 |
Why?
|
| Mice | 2 | 2013 | 81201 | 0.010 |
Why?
|
| Myocardium | 1 | 2007 | 4772 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 18111 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 10183 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 40559 | 0.010 |
Why?
|
| Phenotype | 1 | 2008 | 16367 | 0.010 |
Why?
|
| Aging | 1 | 2008 | 8664 | 0.010 |
Why?
|
| Animals | 2 | 2013 | 168768 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 23404 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 35425 | 0.000 |
Why?
|
| Adolescent | 1 | 2012 | 85779 | 0.000 |
Why?
|